Figure 1

Partitioned survival curves for (A) panitumumab+BSC and (B) BSC alone. BSC=best supportive care; REL=relapse period until death or end of follow up; TOX=days with ⩾grade 3 adverse events; TWiST=time without symptoms or toxicity.